Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase

被引:33
作者
Skarka, Adam [1 ]
Skarydova, Lucie [1 ]
Stambergova, Hana [1 ]
Wsol, Vladimir [1 ]
机构
[1] Charles Univ Prague, Fac Pharm, Dept Biochem Sci, Hradec Kralove 50005, Czech Republic
关键词
Purification; Microsomes; Microsomal fraction; Carbonyl reduction; Anthracyclines; Doxorubicin; Daunorubicin; Idarubicin; Enzyme kinetics; IN-VITRO METABOLISM; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; CHRONIC LYMPHOCYTIC-LEUKEMIA; ANTICANCER DRUG ORACIN; INDUCED CARDIOTOXICITY; REDUCING ENZYMES; DOXORUBICIN; DAUNORUBICIN; INDUCTION; PURIFICATION;
D O I
10.1016/j.cbi.2010.12.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anthracyclines (ANTS) are widely used in the treatment of various forms of cancer. Although their usage contributes to an improvement in life expectancy, it is limited by severe adverse effects acute and chronic cardiotoxicity. Several enzymes from both AKR and SDR superfamilies have been reported as participants in the reduction of ANTs. Nevertheless all of these are located in the cytosolic compartment. One microsomal reductase has been found to be involved in the metabolism of xenobiotics-11beta-HSD1, but no further information has been reported about its role in the metabolism of ANTs. The aim of this study is to bring new information about the biotransformation of doxorubicin (DOX), daunorubicin (DAUN) and idarubicin (IDA), not only in human liver microsomal fraction, but also by a novel human liver microsomal carbonyl reductase that has been purified by our group. The reduction of ANTs at C-13 position is regarded as the main pathway in the biotransformation of ANTs. However, our experiments with human liver microsomal fraction show different behaviour, especially when the concentration of ANTs in the incubation mixture is increased. Microsomal fraction was incubated with doxorubicin, daunorubicin and idarubicin. DOX was both reduced into doxorubicinol (DOXOL) and hydrolyzed into aglycone DOX and then subsequently reduced. The same behaviour was observed for the metabolism of DAUN and IDA. The activity of hydrolases definitely brings a new look to the entire metabolism of ANTs in microsomal fraction, as formed aglycones undergo reduction and compete for the binding site with the main ANTs. Moreover, as there are two competitive reducing reactions present for all three ANTs, kinetic values of direct reduction and the reduction of aglycone were calculated. These results were compared to previously published data for human liver cytosol. In addition, the participation of the newly determined human liver microsomal carbonyl reductase was studied. No reduction of DOX into DOXOL was detected. Nevertheless, the involvement in reduction of DAUN into DAUNOL as well as IDA into IDAOL was demonstrated. The kinetic values obtained were then compared with data which have already been reported for cytosolic ANTs reductases. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:66 / 74
页数:9
相关论文
共 40 条
[1]   Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction [J].
Ax, W ;
Soldan, M ;
Koch, L ;
Maser, E .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (03) :293-300
[2]   Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin [J].
Bains, Onkar S. ;
Takahashi, Ryan H. ;
Pfeifer, Tom A. ;
Grigliatti, Thomas A. ;
Reid, Ronald E. ;
Riggs, K. Wayne .
DRUG METABOLISM AND DISPOSITION, 2008, 36 (05) :904-910
[3]   Two Nonsynonymous Single Nucleotide Polymorphisms of Human Carbonyl Reductase 1 Demonstrate Reduced in Vitro Metabolism of Daunorubicin and Doxorubicin [J].
Bains, Onkar S. ;
Karkling, Morgan J. ;
Grigliatti, Thomas A. ;
Reid, Ronald E. ;
Riggs, K. Wayne .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (05) :1107-1114
[4]  
BAINS OS, 2009, J PHARM EXP THER
[5]   THE ALDO-KETO REDUCTASE SUPERFAMILY AND ITS ROLE IN DRUG METABOLISM AND DETOXIFICATION [J].
Barski, Oleg A. ;
Tipparaju, Srinivas M. ;
Bhatnagar, Aruni .
DRUG METABOLISM REVIEWS, 2008, 40 (04) :553-624
[6]   Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:Quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer [J].
Blanco, Javier G. ;
Leisenring, Wendy M. ;
Gonzalez-Covarrubias, Vanessa M. ;
Kawashima, Toana I. ;
Davies, Stella M. ;
Relling, Mary V. ;
Robison, Leslie L. ;
Sklar, Charles A. ;
Stovall, Marilyn ;
Bhatia, Smita .
CANCER, 2008, 112 (12) :2789-2795
[7]   Uptake of anthracyclines in vitro and in vivo in acute myeloid leukemia cells in relation to apoptosis and clinical response [J].
Bogason, Alex ;
Bhuiyan, Hasanuzzaman ;
Masquelier, Michele ;
Paul, Christer ;
Gruber, Astrid ;
Vitols, Sigurd .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (12) :1179-1186
[8]  
Borchmann P., 1997, International Journal of Clinical Pharmacology and Therapeutics, V35, P80
[9]   The human short-chain dehydrogenase/reductase (SDR) superfamily: A bioinformatics summary [J].
Bray, James E. ;
Marsden, Brian D. ;
Oppermann, Udo .
CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 178 (1-3) :99-109
[10]   Role of anthracyclines in the era of targeted therapy [J].
Cortes-Funes, Hernan ;
Coronado, Cyntia .
CARDIOVASCULAR TOXICOLOGY, 2007, 7 (02) :56-60